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Abstract Long non-coding RNAs are manifested as a new
paradigm of molecular effectors in a wide range of human
diseases. Human SOX2 overlapping transcript (SOX2OT)
gene can generate six lncRNA transcript variants which are
functionally assumed to be correlated with cellular differ-
entiation and carcinogenesis. However, the circumstances
determining expressional and functional differences
between SOX2OT transcript variants remain to be explored.
Here, we studied the expression of all SOX2OT transcript
variants specifically in five human cancer cell lines by real-
time RT-PCR. Changes of the new SOX2OT transcript
variants expression were measured during the NT2 terato-
carcinoma cell line neuronal-like differentiation and were
compared to pluripotency regulators, SOX2 andOCT4Agene
expressions. Surprisingly, we identified two new SOX2OT
transcripts, named SOX2OT-7, SOX2OT-8 which lack exon
8. We discovered that beside active proximal and distal
SOX2OT promoters, different cancer cell lines express high
levels of some SOX2OT transcript variants differentially by
alternative splicing. Significantly, both SOX2OT-7 and
SOX2OT-8 are highly expressed in human cancer cell lines
coinciding with SOX2, one of the pluripotency regulators.
Our results revealed that SOX2OT-7 is almost the most
abundant form of SOX2OT transcript variants in the exam-
ined cancer cell lines particularly in NT2 teratocarcinoma
cell line where its expression falls upon neuronal-like dif-
ferentiation similar to SOX2 and OCT4A. We suggest that at
least some of SOX2OT transcripts are significantly associ-
ated with cancer and stem cell related pathways.
Keywords Long non-coding RNA  SOX2 overlapping
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Background
Although the majority of human genome sequence is
informative and transcribed into RNA products [1, 2]; it is
mostly consists of non protein coding sequences [3, 4].
While the non-coding RNA repertoire of an organism is
considerably related to its evolutionary complexity, protein
coding gene numbers increase less proportionally [5].
Long non-coding RNAs (lncRNAs) assign approximately
80 % of the eukaryotic transcriptome [6]. They are long
([200 nucleotides) mRNA-like transcripts which harbor
post-transcriptional processing and alternative splicing fea-
tures [7]. To date, more than 200 human lncRNAs are doc-
umented in lncRNA database but most of them are not
functionally annotated. The great extent of long non-coding
RNAs elicits regulatory functions in controlling gene
expression events especially at chromatin remodeling, epi-
genetics, transcriptional and post-transcriptional processes
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[7–12]. It has been postulated that lncRNAs can potentially
provide a precursor for other small RNAs [13].
SOX2 overlapping transcript (SOX2OT) is a conserved
lncRNA which encompasses sex determining region Y-box
2 (SOX2) in the same strand [14]. There are evidences
supporting the association of SOX2OT locus (3q26–3q27)
with congenital eye disorders [14, 15]. It is proposed that
SOX2OT function could be related to SOX2, one of the key
regulators of stem cells [14, 16]. SOX2OT gene including
10 exonic regions presents complex transcriptional features
(Fig. 1a); it has at least two transcription start sites, one
located upstream producing SOX2 distal overlapping
transcript (SOX2DOT) variants possessing different 50
nucleotide sequence. Moreover, alternative splicing leads
to the production of six different SOX2OT transcript
variants; three distal variants (transcript variants 1–3) and
three proximal variants (transcript variants 4–6) (Fig. 1b).
The expressions of sox2ot and sox2dot transcript variants
are dynamically regulated during mouse and other mam-
malian embryogenesis [17]. The overexpression of
SOX2OT is also reported in human cancer tissues of breast,
lung and esophagus carcinomas [16, 18–20].
To address the biological importance of SOX2OT
alternative splicing process, here for the first time, we
investigated all SOX2OT splice variants expressions
specifically in five different human cancer cell lines (HeLa,
Mcf7, HepG2, U-87 MG and NT2). Surprisingly, another
new alternative splicing format, joining exons 7–9 was
detected in both distal and proximal transcripts. Along with
the previously reported variants, the expression of two
novel splice variants, named SOX2OT transcript variant 7
and 8 (GenBanks. KF981435, KJ415055) were also quan-
tified. High expression levels of 4, 7 and 8 variants were
detected in all five cancer cell lines; while the rest of
SOX2OT splice variants possessed faint expressions, if
there was any. SOX2 gene expression value in cancer cell
lines is significantly related to SOX2OT transcript variants
7 and 8 (Pearson’s correlation), marking possible biologi-
cal relevance. Notably, neuronal differentiation of NT2
induce a significant SOX2OT-7 expression decline same as
SOX2 and OCT4A which further highlights SOX2OT-7
role in stem cell maintenance regulation.
Methods
Cell culture
Five different human cancer cell lines were selected for this
study. HeLa, MCF7, HepG2, U-87 MG were obtained from
pasture institute (Tehran, Iran) and NTERA-2 (NT2) cell
line was kindly provided by Dr. Peter Andrews (Sheffield
University). NT2 and U-87 MG were cultured in DMEM
F12 (Invitrogen, Gaithersburg, MD) supplemented with
10 % fetal bovine serum (Invitrogen, Gaithersburg, MD)
and 100 IU penicillin-100 lg streptomycin per ml (Invit-
rogen, Gaithersburg, MD) in a 98 % humidified 5 % CO2
incubator. For HepG2, HeLa and MCF7 cell lines, RPMI
1640 (Invitrogen, Gaithersburg, MD) used as growth
medium in same condition.
Neuronal differentiation
NT2 teratocarcinoma cell line was treated with all-trans
retinoic acid (ATRA, Sigma-Aldrich) to differentiate into
Fig. 1 Schematic representation of SOX2OT gene and transcripts.
a SOX2OT gene is regulated by two promoter regions and consists of
10 exons. b Schematic reference sequences of six SOX2OT transcript
variants are illustrated, notice two groups of distal (1, 2, 3) and
proximal (4, 5, 6) variants which are different in 50 end. Alternative
splicing of exons 8 or both 8 and 9 lead to three different 30 end in
proximal variants same as distal transcripts. c Schematic represen-
tation of the two new discovered SOX2OT-8 and SOX2OT-7 are
showed. Notice the new splicing which deletes exon 8. Partially
sequenced region of RT-PCR products is demonstrated by double
arrows. Specific primers binding site used to amplify the transcripts
by RT-PCR are indicated by arrows
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the neuron-like cells, according to a modified protocol
provided by Atlasi et al. [21]. 3 9 104 NT2 cells were
cultured in six-well plates containing 2 ml of growth
medium. After 48 h, medium was replaced by differen-
tiation medium containing 10 lM of ATRA. The treat-
ment was continued for 4 weeks whilst differentiation
medium was renewed twice a week. Cells were harvested
for RNA extraction at time intervals of 0, 3, 7, 14, 21,
32 days.
RNA extraction and reverse transcription
Cells were detached by EDTA/trypsin 0.05 % (Invitrogen,
Gaithersburg, MD) then harvested by centrifugation in
4 C temperature. For total RNA extraction, RNXPlus
solution (Cinnaclon, Iran) was used following the manu-
facturer’s instruction. To deplete possible DNA contami-
nation, 1 lg of total RNA were treated with RNase free
DNaseI (Thermo Fisher Scientific, Inc) for 30 min in 37 C
followed by DNaseI inactivation using EDTA 5 mM at
65 C for 10 min. DNA free RNA was reverse transcribed
by RevertAid first strand cDNA synthesis kit (Thermo
Fisher Scientific, Inc.) using random hexamer primers as
described by the supplier. First strand cDNAs were stored
at -80 C until use.
PCR and semi-quantitative real time-PCR
To amplify target transcripts SOX2 (GenBank: NM_003106.3),
SOX2OT transcript variants 1–6 (GenBanks: NR_075091.1,
NR_075092.1, NR_075093.1, NR_004053.3, NR_075089.1,
NR_075090.1), OCT4A (GeneBank: NM_002701.4) and
GAPDH (GenBank: NM_002046.3); 1 ll of each cDNA was
used as template in a polymerase chain reaction of 5 min initial
denaturation at 95 C, 40 cycles of 10 s denaturation at 95 C,
20 s annealing at 58 C and 40 s extension at 72 C, followed
by 5 min final extension at 72 C in Bio-Rad MJ mini thermal
cycler. Each 25 ll PCR reaction was composed of 2.5 U taq
DNA polymerase (Cinnaclon, Iran), 200 lM dNTPs, 1.5 mM
MgCl2 and 5 pmol each primer. All primers (Table 1) were
designed specifically by Gene Runner software (version 3.02;
Hastings Software, Inc.) and synthesized byMacrogene (South
Korea). PCR products were visualized on prestained 1.5 %
agarose gel after electrophoresis. For new alternative splice
variants target PCR product fragments were extracted from
Agarose gel by GeneJET gel extraction kit (Thermo Fisher
Scientific, Inc) and sequenced directly (Bioneer, South Korea).
Quantitative measurement of gene expression was car-
ried out in Bioer LineGene K and HotTaq EvaGreen qPCR
q-PCR master mix (Cinnaclon, Iran) using the cycling
condition of 15 min initial denaturation and enzyme acti-
vation at 95 C, 40 cycles of 10 s denaturing at 95 C, 15 s
of annealing at 58 C and 30 s of extending at 72 C. Final
melting curve analysis and gel electrophoresis were done to
further confirm the PCR products accuracy.
Statistics
All measurements were performed in triplicate and two no-
sample and no-RT negative controls were included. The Ct
values were normalized to GAPDH as a house keeping
gene and fold changes in gene expressions were normal-
ized to HeLa cell line (2-DDCt). GraphPad Prism version
6.01 was used to analyze data statistically. One sample
student’s t test (fixed value = 1) was used for cell line gene
expression experiment analysis and All data presented as
log 10 of mean ± SE. For NT2 differentiation statistics,
the 2-way ANOVA multiple comparison test (Bonfer-
roni’s) was carried out versus time point zero as a control.
To explore any relation between gene expression levels of
target genes a Pearson r correlation test was applied.
Results
Identification of a new format in alternative splicing
of SOX2OT transcripts
Using specific primers (Table 1), SOX2OT transcript
variants were amplified separately using RT-PCR in U-87
MG cell line. As presented in Fig. 2, while specific
amplifications of variant 5 (F2, R4) and variant 6 (F2, R5)
resulted in two fragments of 398 (Fig. 2a lanes 7–9) and
111 base pairs (Fig. 2a lanes 10–12); no expression of
variants 2 and 3 were detected (data not shown). Surpris-
ingly, gel electrophoresis indicated two extra amplified
fragments when SOX2OT transcript 1 (F1, R1) and
SOX2OT transcript 4 (F2, R1) specific primers were used
for PCR reaction (Fig. 2a, lanes 2, 3 and 4–6). To examine
nonspecific hybridization of primers, annealing tempera-
ture was increased to 3 C in a gradient PCR (56, 57 and
58 C); and the results indicated more intense amplification
of same extra PCR fragments in both S1 and S4 reactions
in high temperature conditions (Fig. 2a, compare lanes 1–3
and 4–6). Since both extra bands (*168 and 129 bps)
differ in length from original SOX2OT transcript variants 1
and 4 PCR products (454 and 415 bps) by about 286
nucleotides (equal to length of exon 8); we proposed
existence of two new alternative splice variants lacking
exon 8. To explore the idea, the 129 and 168 bps fragments
were sequenced directly following agarose gel purification.
Nucleic acid sequences revealed a new exon 7–9 junction
in both proximal and distal SOX2OT transcript variants
submitted as SOX2OT transcript variant 7 (GenBank:
KF981435) and SOX2OT transcript variant 8 (GenBank:
Mol Biol Rep (2016) 43:65–72 67
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KJ415055) respectively (Fig. 1c). Then for more assur-
ance, a reverse primer spanning 7–9 exon boundary (R6)
was used to amplify SOX2OT transcript variant 7
(104 bps, Fig. 2b, lane 15) and SOX2OT transcript variant
8 (139 bps, Fig. 2b, lane 13) specifically by RT-PCR.
Similarly a reverse primer specific for the 9–10 exon
junction was used for specific amplification of SOX2OT-1
(424 bps, Fig. 2b, lane 14) and SOX2OT-4 (389 bps,
Fig. 2b, lane 16) in human cancer cell lines.
SOX2OT variant 7 and 8 are highly expressed
in human cancer cell lines
We screened the expression level of two novel transcripts,
SOX2OT-7 and SOX2OT-8 in five selected human cancer
cell lines (HeLa, MCF7, HepG2, U-87 MG and NT2) by
Real time RT-PCR. To facilitate the comparison of cell
lines, HeLa cell line (which showed the least expression
values) was considered as calibrator. Unexpectedly, all
tested cancer cell lines, especially NT2 showed high
levels of SOX2OT-7 and SOX2OT-8 expressions; except
Mcf-7 which expresses the minimum level of SOX2OT-8
(Fig. 3a).
Regarding to the supposed association of SOX2OT
transcripts and SOX2 gene, we explored the expression
levels of SOX2 and OCT4A, the pluripotency regulators in
accordance to SOX2OT-7 and SOX2OT-8. SOX2 and
OCT4A gene expressions were also quantified in all cell
lines using the same method. As shown in Fig. 3a, high
levels of SOX2 expression was detected in all cell lines
same as SOX2OT transcript variants; however OCT4A
expression was observed in some of studied cell lines. One-
sample student’s t test (CI 95 %, alpha = 0.05) indicated
that the means of SOX2 (P value = 0.008), SOX2OT-7
(P value = 0.02), SOX2OT-8 (P value = 0.03) fold chan-
ges are significantly different from fixed theoretical value of
1. Pearson r correlation test (CI 90 %, alpha = 0.1) indi-
cated significant correlation between expression values of
SOX2OT-7 and SOX2OT-8 (r = 0.95, P value = 0.003),
SOX2 and SOX2OT-7 (r = 0.75, P value = 0.08).
SOX2OT-7 is the most abundant isoform
of SOX2OT transcripts in NT2, U-87MG
and HepG2 cancer cell lines
Considering the importance of SOX2OT-7 and SOX2OT-8
along with other SOX2OT variants, we studied the
SOX2OT profile in three cancer cell lines (U-87MG, NT2,
HepG2). The expression levels of SOX2OT transcript
variants 1, 4, 5, 6, 7, 8 were specifically measured in
triplicate by real time RT-PCR. The Ct values were nor-
malized to GAPDH as an internal control and 1/DCt per-
cent was illustrated to compare SOX2OT transcript
variants in each cell line. Results showed that the transcript
variants of SOX2OT 4, 5, 6, 7 and 8 are expressed in three
tested cell lines and interestingly, SOX2OT-7 assign high
expression scores in comparison to other SOX2OT tran-
scripts (Fig. 3b). SOX2OT transcript variant 7 occupies
[90 % of total SOX2OT transcript variants measured in
NT2 teratocarcinoma cell line,[55 % in U-87MG glioma
cell line and[35 % in HepG2 hepatocellular cancer cell
line. No significant levels of SOX2OT-1 and SOX2OT-5
were detectable in three selected cancer cell line.
SOX2OT-7 expression decreases along with NT2 cell
line neuronal induction
In relation to other transcript variants of SOX2OT, high
expression levels of SOX2OT-7 transcript in NT2 terato-
carcinoma cell line highlights a potential association of
SOX2OT-7 with stemness features of the cells. We then
interested to measure whether SOX2OT-7 expression
Table 1 Specific primer
sequences used for
amplification of target genes
Primer Primer sequence 50?30 Specific for
F1 TTCAGAAACTTATCAAGAGGTTC SOX2OT exon 5 (variants 1, 2, 3, 8)
F2 TCTGTTCAGTATTTGGAAGAAAG SOX2OT exon 6 (variants 4, 5, 6, 7)
R1 GCAGAGATTATCCGATTTGG SOX2OT exon 9 (variants 1, 4, 7, 8)
R2 TTGGACCCGCGATGTC SOX2OT exon 9–10 boundary (variants 1, 4)
R4 ACATTATTTCTAAGTTGGATATGTC SOX2OT exon 8–10 boundary (variants 2, 5)
R5 CATTATTTCTAAGTTGGATTGGA SOX2OT exon 7–10 boundary (variants 3, 6)
R6 GCTTGGACCCGCGTG SOX2OT exon 7–9 boundary (variants 7, 8)
F3 TACAGCATGTCCTACTCGCAG SOX2
R8 GAGGAAGAGGTAACCACAGGG
F4 GAGCGAGATCCCTCCAAAAT GAPDH
R9 GGCTGTTGTCATACTTCTCATG
F5 TTCGCAAGCCCTCATTTCAC OCT4A
R10 CGAGAAGGCGAAATCCGAAG
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specifically is altered during NT2 neuronal-like induction
mediated by all-trans retinoic acid treatment. NT2 cells
were induced to differentiate to neuronal-like lineage and
cells were harvested for RNA extraction and gene
expression analysis in six time points (0, 3, 7, 14, 21,
32 days). SOX2OT-7, SOX2 and OCT4A gene expression
levels were measured by Real time RT-PCR and normal-
ized to GAPDH. Mean fold changes of gene expressions
relative to Day zero are presented (Fig. 4). As expected,
SOX2 expression falls significantly from 7 to 32 days of
differentiation (P value \0.01) and almost no OCT4A
expression remains detectable after 7 days of differentia-
tion (P value \0.0001). Notably, SOX2OT-7 expression
declines upon NT2 differentiation similar to SOX2 and
OCT4A, two master regulators of pluripotency. Following
21 days of Retinoic acid treatment SOX2OT-7 expression
Fig. 2 Gel electrophoresis of RT-PCR products of SOX2OT tran-
script variants amplification in U-87 MG cell line. a Temperature
gradient of annealing temperatures 56–58 C was applied for primer
annealing step of RT-PCR reactions. Specific RT-PCR products of a
454 base pairs SOX2OT-1 product (lane 2); a 415 base pairs
SOX2OT-4 product (lanes 4–6); a 398 product of SOX2OT-5 (lanes
7–9) and 111 base pairs SOX2OT-6 products (lanes 10–12) are
shown. Noticeably extra bands of 168 bps in SOX2OT-1 reaction
(lanes 2–3) and 129 bps in SOX2OT-4 reaction (lanes 4–6) have got
more intensity parallel to annealing temperature increase. The length
of extra fragments, interestingly differ about 286 nucleotides (exon 8)
from original variants and potentially have been proposed as two new
variants. b Using R2 and R6 Reverse primer specific for new exon
boundaries, the specific amplification products of a 139 base pairs
predicted SOX2OT-8 (lane 13), a 424 base pairs of SOX2OT-1 (lane
14), a 104 base pairs predicted SOX2OT-7 (lane 15) and a 389 base
pairs of SOX2OT-4 (lane 16) are presented. c The primer and product
description of each lane is presented in this table
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reduced up to zero (P value\0.0001); however it increased
to 0.5 fold at 32th day.
Discussion
According to the fact that the primary sequence of a
polynucleotide determines its three-dimensional structure,
it is not amazing that alternative spliced or alternative
promoter mediated of non-coding transcripts can poten-
tially exert different features in stability, 3-D folding,
localization and even function. The minimum free energy
prediction of two SOX2OT-4 and SOX2OT-7 isoforms was
calculated by RNA Fold web server (http://rna.tbi.univie.
ac.at/cgi-bin/RNAfold.cgi). Surprisingly, we found that
splicing of the exon 8 (286 nucleotides in length) can
obviously affect the infrastructure of SOX2OT-4 transcript
and increase the minimum free energy of SOX2OT-7
secondary structure about 110 kcal/mol (data not shown).
Beside less predicted structural stability relative to variant
4, SOX2OT-7 has significantly more cellular concentration
in NT2, HepG2 and U-87MG cell lines. It seems that the
higher expression of SOX2OT-7 is regulated post-tran-
scriptionally, since both SOX2OT-4 and SOX2OT-7 are
transcribed from same promoter. Indeed, partial confor-
mational entropy of SOX2OT-7 may be considered as a
functional advantage providing the structural dynamic
necessity for a functional non coding RNA.
Cell type specific regulation of a non-coding RNA
expression provides a clue for its functional importance
[22]. Recently, Askarian-Amiri et al. [19] demonstrated
SOX2OT gene expression differentially in estrogen positive
breast cancer tissue and cell lines in concordant with SOX2.
They also showed that the overexpression of SOX2OT is
directly associated with SOX2 gene up-regulation. Hou
et al. [20] ascertained the role of SOX2OT in lung cancer
progression and illustrated SOX2OT overexpression in
lung tumor tissue and cell line. Shahryari et al. [16]
reported three human SOX2OT splice variants named
SOX2OT, SOX2OT-S1 and SOX2OT-S2 (GenBanks:
NR_004053.2, JN711430.1 and JN882275.1) later updated
to SOX2OT transcript variants 4, 5 and 6 which are over
expressed in esophagus cancer tissues.
In the present study, instead of SOX2OT general gene
expression measurement, we focused on different transcript
variants of SOX2OT specifically in human cancer cell lines
and identified two new SOX2OT transcript variants for the
first time. We presented different SOX2OT transcripts that
Fig. 3 Graph presentation of real time RT-PCR amplification of
target genes. a Semi-quantitative comparison of SOX2OT-7,
SOX2OT-8, SOX2 and OCT4A genes expression level in five different
human cancer cell lines. Log of fold change (2-DDCt) was computed
relative to HeLa cell line. GAPDH gene expression was used as the
housekeeping gene control to normalize Ct values. Notice the high
expression of SOX2OT-7 and SOX2OT-8 coincident with SOX2 and
OCT4A genes. b SOX2OT variants expressional profile of each cell
line indicated as Mean of 1/DCt of each SOX2OT variants to total of
all detectable variants 9 100 in each cell line. High expressional
score of SOX2OT-7 is remarkably illustrated in SOX2OT profile of
each cell line
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among them two novel SOX2OT-7 and SOX2OT-8 are
highly expressed in five different human cancer cell lines;
suggesting the potential role of SOX2OT transcripts in
carcinogenesis.
There are evidences indicating the probable role of
SOX2OT in development and stem cell regulation. Dif-
ferent isoforms of sox2ot are precisely regulated during
mammalian embryogenesis and like SOX2; sox2ot
expression is down-regulated along with the differentiation
of mouse ESC [17]. Breast cancer stem cell enrichment
mediated by suspension culture increases SOX2OT and
SOX2 gene expression levels [19]. Indeed SOX2OT
(variants 4, 5, 6) expression decrease in parallel with NT2
neuronal-like differentiation as same as SOX2 and OCT4A
[16]. Interestingly, in NT2 cancer cell line with stem cell
like properties, high expression of SOX2OT-7 in compar-
ison to other variants, highlights it as the SOX2OT iso-
forms most related to pluripotency. Here, we also
demonstrated that the expression of SOX2OT-7 specifi-
cally decreases along with NT2 differentiation as same as
SOX2 and OCT4A, but there is a slight raise in SOX2OT-7
expression observable at the end of differentiation (day 32).
Previously, Amaral et al. [17] have shown that sox2ot
expression remains high when mouse embryonic body
differentiates to mesoderm lineage.
It has been postulated that distal promoter of SOX2OT
is merely active in neuronal lineage [17, 23]; however our
results illustrated that both proximal and distal SOX2OT
promoters are constitutively active in all studied cancer cell
lines of different histological origins; which could be rel-
evant to changes obtained during carcinogenesis. Although
the functional properties of different SOX2OT isoforms are
not exactly determined yet, but studies suggest that the
association of SOX2OT with SOX2 regulation in stem cells
[16, 17, 19, 24] and G2/M cell cycle progression in cancer
cells [16, 19]. Concerning the regulated expression and
splicing of different transcript isoforms of SOX2OT as a
long non-coding RNA, we propose that each SOX2OT may
potentially function diversely and should be addressed in
separate.
Conclusion
Our results suggest that the two novel alternative spliced
variants of SOX2 overlapping transcripts, SOX2OT-7 and
SOX2OT- 8 are highly associated with different human
cancer cell lines and are over expressed coincidingwithSOX2
gene which is transcribed in same direction. In comparison to
other SOX2OT transcripts, cancer cell lines favor SOX2OT-
7 and SOX2OT-8 transcript expression propounding a plau-
sible function in carcinogenesis. The marked direct associa-
tion of SOX2OT-7 and stemness features of NT2 cell line,
indicates its potential role in pluripotency. Counting these
two novel spliced variants, altogether eight different tran-
scripts of SOX2OT have been identified to date and their
functional differences still remain to be investigated.
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